Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02339220 · ClinicalTrials.gov registry record · NA
The Brave Initiative: Bringing Rehabilitation to American Veterans in an Enriched Environment
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT02339220: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT02339220 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02339220, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the value of Constraint-Induced Movement therapy (CIMT) for improving motor function and general fitness in adults with subacute and chronic traumatic brain injury (TBI), particularly TBI acquired during active military duty, in comparison to a Lakeshore Enriched Fitness Training (LEFT). The study will also test the effect of a set of enhanced versus "standard" procedures for transferring therapeutic gains from treatment setting to everyday life. Lastly, this study will determine whether any therapeutic effects observed are correlated with neuroplastic white matter or grey matter changes.
Primary Outcome
The Motor Activity Log (MAL) is a structured interview intended to examine how much and how well the subject uses their more-affected arm outside of the laboratory setting.
Interventions
- BEHAVIORAL Constraint-Induced Movement Therapy (CIMT)
- BEHAVIORAL Lakeshore Enriched Fitness Training (LEFT)
- BEHAVIORAL standard Transfer Package (sTP)
- BEHAVIORAL enhanced Transfer Package (eTP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2016-09 |
| Est. Completion | 2019-04-24 |
| Phase | NA |
What the finished NCT02339220 record still lists
NCT02339220 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Constraint-Induced Movement Therapy (CIMT) is the first listed.
NCT02339220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02339220 about?
NCT02339220 is a clinical study titled "The Brave Initiative: Bringing Rehabilitation to American Veterans in an Enriched Environment". The purpose of this study is to determine the value of Constraint-Induced Movement therapy (CIMT) for improving motor function and general fitness in adults with subacute and chronic traumatic brain injury (TBI), particularly TBI acquired during active military duty, in comparison to a Lakeshore Enr...
What is the current status of trial NCT02339220?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2016-09. Estimated completion is 2019-04-24.
What interventions are being tested in trial NCT02339220?
The interventions under investigation include: Constraint-Induced Movement Therapy (CIMT) (BEHAVIORAL), Lakeshore Enriched Fitness Training (LEFT) (BEHAVIORAL), standard Transfer Package (sTP) (BEHAVIORAL), enhanced Transfer Package (eTP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02339220?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02339220's enrollment target sits among peer trials
42 1436th of 2000 higher than 555 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia